The world's richest man started by developing gutter oil

The emergence of the HIV virus shocked the world once before, and this time the launch of the HIV vaccine shocked the world again.

Medical representatives from all over the world have sent their Chinese regional counterparts to negotiate vaccine agency matters.

Even though Zhou Shuyan has given priority to meetings with top-ranked pharmaceutical companies, her schedule has already been booked until the end of this year.

Office of the President of Deep Blue Group.

At this moment in the office, Han Chen was talking to Zhou Shuyan about vaccine authorization.

“Don’t negotiate with any Jewish financial group. If you want to negotiate, negotiate with local financial groups in various countries. So before you discuss cooperation, you must investigate the other party’s background and identity. In addition, mark the right to terminate cooperation without liability in the contract.

These companies may not be Jewish conglomerates today, but they may very likely become Jewish conglomerates tomorrow.

From now on, the company will not be allowed to license any of its products to companies controlled by Jewish consortiums.

In addition, the global price of HI vaccine is set at 69 US dollars, the wholesale price to agents is 39 US dollars, and the price in the United States is set at 169 US dollars, and the wholesale price to the United States is 120 US dollars. "Han Chen said.

Over the years, the Jewish consortium has been annoying him behind his back, so Han Chen plans to support some local consortiums. Only with the support of local consortiums in various countries can Deep Blue compete with the Jewish consortium internationally.

Therefore, Han Chen now asks them not to cooperate with Jewish groups when choosing partners.

Today, the most profitable fields in the world have been occupied by Deep Blue Group.

In another thirty to fifty years, the Jewish group will surely decline.

"Okay, Mr. Han." Zhou Shuyan replied.

April 2016, 6, US time.

The prices of HIV vaccines outside China were exposed by the media.

Since the price of the vaccine has already been set, Deep Blue did not require a confidentiality contract, so it is normal for the price to be exposed.

"I thought the HIV vaccine Deep Blue would be very expensive, but I didn't expect the global retail price to be only US$69. This price is still very reasonable."

"This price is already twice as expensive as in China. In China, an injection only costs 29 US dollars."

"These vaccines are all produced in China. Transportation, production, storage, and tariffs all cost money. 69 is very cheap after taking into account all the costs. If you think it's expensive, you can go to China to get the vaccine."

"Why does America charge 169 dollars per shot? Is Deep Blue discriminating against Americans? Why are American products so much more expensive than those in other countries?"

"Could it be that your country has a problem? Your country has been madly raising taxes on dark blue products, and after the taxes are raised, the price will naturally go up."

"It's great that you can get the vaccine. India doesn't even have the vaccine because there is no India in the world."

"India doesn't need HIV vaccine, cow urine and Ganges water are enough for them."

"I was inexplicably tickled by the comment above. Even though I'm a professional I couldn't help but laugh."

"Is it possible that even if the deep blue is willing to sell the vaccine to them, 90% of the Indians cannot afford the vaccine, and even if they do, it will not eradicate HIV."

"As a senior high school student in India, I think what the above person said makes a lot of sense, and I have no way to refute it."

"Haha, with this, you don't have to worry about contracting HIV anymore."

"Emmm, you should know that in addition to HIV, there are also HPV, TP, STD and other viruses."

"What you said can be cured with money, but HIV cannot be cured even with money."

"I just don't know when the vaccine will arrive so I can go out and have fun. There are many brothers waiting for me out there."

"Shit, that upstairs couldn't be the virus mother."

September 2016, 6, China time.

Deep Blue Institute of Traditional Chinese Medicine.

The lighting in the laboratory is soft and focused.

Hu Guanliang's figure shuttled back and forth in the laboratory, his eyes fixed on the transparent biosafety cabinet, where autologous immune cells that were about to undergo final verification were cultured.

After half a year of hard work day and night, with the help of the new generation of Shennong AI, they finally reached this step.

On the experimental table, various precision instruments made slight humming sounds, indicating that they were operating.

In a corner of the room, several researchers were recording data with their heads down, their pens working out complex formulas and data on paper. Everyone's face was filled with seriousness and anticipation.

Hu Guanliang's fingers tapped gently on the transparent observation window. The cells inside were slowly dividing in the culture medium, full of vitality.

He knew that if the experiment was successful, it would be a major breakthrough in the medical field and could bring new hope to countless patients.

As time passed, a hint of tension and anxiety appeared in the eyes of the team members.

Hu Guanliang was unusually calm, his eyes flashing with determination and conviction.

He knew that this moment not only concerned their research results, but also the fate of countless lives in the future.

Finally, the experimental data began to show signs of results, with the activity and adaptability of the cells being better than expected.

Hu Guanliang and his team members exchanged glances, and they were filled with excitement and excitement.

They knew they were only one step away from victory.

They successfully used this technology to eliminate cancer cells in the experimental body. The next step is clinical trials on humans. As long as the clinical trials on humans successfully verify their drug.

This means that humans have defeated cancer, which is known as one of the top ten incurable diseases in humans and is curable.

Many researchers shed tears of excitement at this moment.

“We are halfway there.”

"As long as we can pass human clinical trials, we will go down in human history."

"The sleepless work over the past six months has finally paid off."

"Oh my god, I'm going to go back and sleep with him for three days and three nights. If this continues, I'm really going to go crazy."

"I can finally go back and rest."

Just as the research team was discussing, Hu Guanliang walked out alone.

After Hu Guanliang walked out of the laboratory, he picked up the landline outside the laboratory and called the dean's cell phone, Tu Jiaojiao.

Half past two in the afternoon.

The President's Office of Shenlan Group in Shenlan Industrial Park.

Han Chen just came out of the lounge and saw a pop-up window on the computer. Tu Jiaojiao sent him an email 20 minutes ago. The content of the email was that Hu Guanliang's research and development team had developed an autologous immune cell cancer treatment method through Shennong AI deduction.

This treatment method is of the same type as the previous generation's CAR-T million cancer shots.

AR-T therapy is chimeric antigen receptor T cell immunotherapy, whose full English name is Chimeric Antigen Receptor T-Cell Immunotherapy.

This is a new type of precision targeted therapy for treating tumors. In recent years, through optimization and improvement, it has achieved good results in clinical tumor treatment. It is a very promising new tumor immunotherapy method that is accurate, fast, efficient, and has the potential to cure cancer.

T cells, also called T lymphocytes, are a type of white blood cell in the human body. They originate from hematopoietic stem cells in the bone marrow, mature in the thymus, and then migrate to the human blood, lymph and surrounding tissues and organs to exert immune functions.

Its function is equivalent to that of a "warrior" in the human body, capable of resisting and eliminating "enemies" such as infection, tumors, and foreign bodies.

In the laboratory, technicians use genetic engineering technology to activate T cells and install a positioning and navigation device CAR (tumor chimeric antigen receptor), transforming T cells, an ordinary "warrior", into a "super soldier."

That is, CAR-T cells, which use their "positioning navigation device" CAR to specifically identify tumor cells in the body and release a large number of multiple effector factors through immune action. They can effectively kill tumor cells, thereby achieving the purpose of treating malignant tumors.

Later generations of CAR-T therapy can only treat some specified cancers.

However, the CAR-T therapy developed by Hu Guanliang can treat all cancers.

Because this autologous CAR-T treatment method requires cancer cells and T cells in the patient's body to be recompiled in order to accurately kill cancer cells.

The secondary compilation of T cells is performed through Shennong AI, so its accuracy is higher than that of previous CAR-T.

With the support of AI, the secondary compilation of T cells can be fully automated, and the cost of secondary compilation of T cells is lower than that of manual compilation by technicians.

According to the report sent by Tu Jiaojiao, the cost of producing one dose of CAR-T immune injection is only about 6 RMB.

This cost refers to the cost of fully automated compilation by machine. If it is compiled manually, the cost will be at least 10 yuan, and the production efficiency of manual compilation is extremely low.

The only difficulty now is to produce the T cell compilation device. Tu Jiaojiao applied to cooperate with other companies to produce the equipment.

After reading the report sent by Tu Jiaojiao, Han Chen picked up the phone on the table and called him.

Tu Jiaojiao answered the phone and greeted, "Mr. Han."

Han Chen asked: "I have already looked into the equipment manufacturing. There is no need to find a foreign company to cooperate with. The group has a team that can make it."

Tu Jiaojiao replied: "Ah? Is there a team in the group's company that can do this?"

Han Chen said: "Yes, Deep Blue Machinery under the group can produce machines of this level. I will send you their contact information later."

Tu Jiaojiao said excitedly: "It's great that the company has a team that can produce it. This way we don't have to worry about the technology leaking."

"Okay, if there's nothing to do, I'll hang up." Han Chen hung up the phone after saying that.

Han Chen then sent a message to Carol, the head of R&D at DeepBlue Machinery, that is, the team that developed the OLED printer. They were able to produce equipment with the precision required by Hu Guanliang.

OLED printers and cell-editing equipment don't seem to go together.

In fact, they are all high-precision production equipment. As long as they are high-precision equipment based on mechanical principles, it is not a difficult task for Carroll.

Even some of the production equipment at the wafer factory were improved under the leadership of Carroll.

September 2016, 6, China time.

On a sunny afternoon, outside the factory of Liuzhou Wuling Automobile Company, there was a bustling crowd and it was very lively.

A brand new electric car was parked quietly in the center of the booth. It had smooth lines and its body was painted in a deep night blue color, reflecting a soft luster.

The design of this model is simple yet futuristic, and every detail reveals refinement and ingenuity.

The LED headlights on the front of the car are as sharp as eagle eyes, as if they can see through all obstacles.

The side waistline runs through the front and back, like a soaring dragon, full of power and dynamism.

The wheel hub has a unique design, and its rotation seems like the flow of time and space, which is very inspiring.

The shape of the rear of the car is round and full, and the taillights are inlaid like gems, emitting charming light.

Open the door and you will be greeted by the luxurious interior. The seats are wrapped in environmentally friendly leather, which is delicate and comfortable to sit on.

On the center console, a large-size LCD screen shines brightly, integrating many intelligent operations of the vehicle.

On the steering wheel, the multi-function buttons are arranged in an orderly manner, showing the technological and humanized design.

With a smile on their faces, the staff of Liuzhou Wuling introduced the performance and features of the new car to the media and customers watching.

The range is 268 kilometers, which is undoubtedly amazing for an electric car that costs only 6.9 yuan.

The faces of the automotive industry insiders present were more or less shocked. They realized that the launch of this electric car would reshape the market landscape and trigger fierce competition.

For ordinary consumers, this means that they will be able to enjoy high-performance electric vehicles at affordable prices, making travel more economical and environmentally friendly.

"It's crazy. Liuzhou Wuling's electric car costs 6.9 yuan. How can other car companies survive?"

"Wuling produces what the people want."

"Although this car only has a range of 268 kilometers, it is enough for use in the city. It is very cost-effective to pick up children from get off work. At this price, I can save the money for the car in two years."

"It's a pity that this car doesn't support fast charging technology. It would be perfect if it did."

"Brother, you still want fast charging technology for 6.9 yuan, wouldn't it be better to just charge it at home? It costs 1 yuan to fast charge a kilowatt-hour outside, but only 2 cents to charge at home."

"You have to stand in someone else's place to fast charge outside, so it's normal that fast charging is more expensive."

"It's very cheap to charge in the city for 1 yuan. Last time I charged on the highway, it cost 2 yuan. Fortunately, I don't travel to other places often."

"Even at 2 yuan per kWh, it's still much cheaper than driving a gasoline car."

"I think BMW is going to cry in the toilet. Who would buy a fuel car when there is an electric car for 6.9 yuan?"

"That's not the case. A fuel-powered car can travel long distances, but your car can't."

"The problem is that I can save the gas money for a car in two years, but can you save that much money by driving a gasoline car for three years?"

"Emm, this is indeed not possible."

"Believe it or not, other domestic car brands will launch electric cars priced around 10 yuan in a few days."

"The guy above, please be more confident. Wuling can sell for 6 yuan, so it's not unusual for other brands to sell for 9 yuan."

"Fuck, guys, hurry up and log on to DeepBlue Medical Devices. DeepBlue Group is going to launch another black technology, and this time the black technology is even more awesome. I was originally planning to end my life at the end of the year, but after seeing this news, I have regained my confidence in living."

"What on earth is wrong with this big brother that he wants to commit suicide?" (End of this chapter)